Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
3 Dividend Stocks You Can Buy Without Any Hesitation
06:14am, Saturday, 03'rd Jun 2023
Bristol Myers Squibb is a biopharmaceutical industry stalwart that pays a high dividend. Gilead Sciences' valuation is cheap, and its dividend continues to grow.
High Yield Stock Watchlist: June 2023
11:43am, Friday, 02'nd Jun 2023
There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. An equally weighted portfolio of these stocks u
Pfizer secures FDA clearance for RSV vaccine in older adults
12:26pm, Thursday, 01'st Jun 2023
Pfizer Inc (NYSE:PFE) has gained approval from the US Food and Drug Administration (FDA) for its respiratory syncytial virus (RSV) vaccine in older adults. The New York-based company's vaccine, called
Pfizer says its experimental antibiotic combo can treat some superbug infections
10:25am, Thursday, 01'st Jun 2023
Pfizer Inc said on Thursday that data from its late-stage trials showed its experimental combination of antibiotics was effective in treating some infections caused by drug-resistant bacteria.
Dividend Harvesting Portfolio Week 117: $11,700 Allocated, $980.26 In Projected Dividends
09:00am, Thursday, 01'st Jun 2023
The Dividend Harvesting Portfolio has a balance of $11,381.73, with a decline of -2.72% on invested capital. The projected annual dividend income increased by 0.79% to $980.11, with a forward yield of
Pfizer's (PFE) RSV Vaccine for Older Adults Gets FDA Approval
08:49am, Thursday, 01'st Jun 2023
The FDA approves Pfizer's (PFE) RSV vaccine, Abrysvo, for older adults, making it the second RSV vaccine to be approved by the regulatory agency.
Have $2,000? 2 Remarkable Growth Stocks to Buy Right Now
07:45am, Thursday, 01'st Jun 2023
The healthcare industry has traditionally been one of the most non-cyclical spaces for investors. Pfizer isn't done growing even as the boom brought about by its COVID-19 products recedes.
FDA Approves Pfizer's RSV Vaccine For Older Adults—It Could Be Available This Fall
04:54am, Thursday, 01'st Jun 2023
The agency is also considering approving the RSV shot for pregnant people to protect infants from birth.
Pfizer gets FDA approval for RSV vaccine Abrysvo in older adults
06:53pm, Wednesday, 31'st May 2023
Pfizer Inc. PFE said late Wednesday that the Food and Drug Administration approved its respiratory syncytial virus vaccine Abrysvo for older adults. The drug maker said the FDA approved Abrysvo for us
FDA approves Pfizer RSV vaccine for older adults
06:40pm, Wednesday, 31'st May 2023
The approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a similar shot made by GSK.
US FDA approves Pfizer's RSV vaccine
05:58pm, Wednesday, 31'st May 2023
The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory dise
Why Pfizer Stock Is Perking Up Today
02:59pm, Wednesday, 31'st May 2023
A WSJ column spotlighted Pfizer's hefty sell-off this year over its falling COVID-19 product sales. With the bearishness likely overdone, bargain hunters appear to be bidding up the drugmaker's stock
Pfizer (PFE) Posts Upbeat Data From Hemophilia Drug Study
01:16pm, Wednesday, 31'st May 2023
Data from a late-stage study shows that treatment with Pfizer's (PFE) experimental anti-TFPI inhibitor led to a significant reduction in annualized bleeding rate in hemophilia A and B patients.
Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic?
09:53am, Wednesday, 31'st May 2023
Pfizer's diabetes and weight-loss pill danuglipron showed some positive results in trials. Participants achieved similar weight loss to Novo Nordisk's Ozempic over a faster time.
2 Ultra-Safe Dividend Stocks to Load Up On Right Now
06:45am, Wednesday, 31'st May 2023
Blue chip dividend stocks tend to produce market-beating returns over long periods of time. Several top-shelf dividend stocks have yet to recover from the 2022 bear market.
